Within two to four weeks we find potential targets/biomarker candidates or do a detailed target/biomarker assessment. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll contact you to discuss next steps.

Use our platform to find novel target/biomarker candidates or do detailed target/biomarker assessment yourselves. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll set up a demo to show you!

Please contact me to discuss:

Subscription to Euretos AI Platform
Euretos consulting service
Direct access to Euretos API

Do you have a question on gene-disease associations that are not covered on this page? Or would you like to know more about the Euretos AI Platform? Please fill in your contact details and we will reach out to you!


Read the newest articles about gene disease here.



In Silico
Biomarker Discovery

Discover signature dysregulations in the molecular mechanisms involved in the cell, tissue functions and phenotypes associated with your disease of interest. Assess their suitability as biomarkers on multiple criteria. Available as platform subscription or consulting service.



Discover signature dysregulations in the molecular interactions driving disease pathology

Leverage our millions of gene annotations and combine these with your personal data. Discover and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology. Identify signature dysregulations resulting from these pathologies.


Specific, Predictive and Non-Invasive Biomarkers

From the list of potential signature dysregulations, evaluate most promising biomarkers by ranking, filtering and scoring simultaneously on multiple key aspects such as differential expression and bioavailability.


Summary of Biomarker Discovery Capabilities

Create and upload gene lists - Leverage the millions of gene annotations in the platform to find candidate targets that meet very specific criteria. Upload your own gene expression and annotation lists to include in your analysis.

Broaden your understanding of the disease mechanism - Overlay multiple gene lists, each associated with specific disease characteristics, to find the most highly involved genes. Discover novel aspects of the disease mechanism (such as associated pathways, metabolites, molecular mechanisms etc) through embedded analytics algorithms.

Evaluate expression and bioavailability and novel disease association simultaneously - Get a prioritised list of biomarkers, which are highly expressed and where over 95% are novel disease associations predicted by the powerful 'embedded’ biomarker discovery analytics.

Analyse disease mechanism with incredible detail - Assess the biomarker and (novel) disease association on key biomarker discovery aspects such as gene stimulating & inhibiting molecules, gene expression, comorbidity, gene-gene interactions, small & macro molecular interactions and impacted physiological processes & pathways. This instant biomarker discovery analysis would normally take days to perform.

Instantly assess bio availability to find non-intrusive biomarkers - Assess at a glance the key biomarker discovery aspect of bio-availability: secreted, plasma, cytoplasma, extracellular space or membrane.